# Treating Nocturnal Hypertension and Nocturia in African American Men

> **NCT03319823** · PHASE4 · WITHDRAWN · sponsor: **Cedars-Sinai Medical Center**

## Conditions studied

- High Blood Pressure

## Interventions

- **DRUG:** Thiazide Treatment Group
- **DRUG:** Intensified Thiazide Treatment Group
- **DRUG:** Combination Medication Treatment Group

## Key facts

- **NCT ID:** NCT03319823
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-25
- **Primary completion:** 2019-02-13
- **Final completion:** 2021-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to the Pandemic, we decided to end this study.
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319823, "Treating Nocturnal Hypertension and Nocturia in African American Men". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03319823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*